The binding of PD-L1 to PD-1 on T cells disrupts signalling pathways, leading to reduced immune surveillance, T-cell exhaustion, and apoptosis, which allows tumour cells to evade immune detection (9–11). This evidence concerns the gene CD274 and neoplasm.